scispace - formally typeset
G

Gustaaf Borghs

Researcher at Katholieke Universiteit Leuven

Publications -  637
Citations -  17758

Gustaaf Borghs is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Molecular beam epitaxy & Quantum tunnelling. The author has an hindex of 65, co-authored 637 publications receiving 17040 citations. Previous affiliations of Gustaaf Borghs include VU University Amsterdam & The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Silane Ligand Exchange to Make Hydrophobic Superparamagnetic Nanoparticles Water-Dispersible

TL;DR: Ferrite magnetic nanoparticles (MNPs) were functionalized with a variety of silanes bearing different functional endgroups to render them stable with respect to aggregation and keep them well-dispersed in aqueous media as discussed by the authors.
Journal ArticleDOI

Biosensing based on light absorption of nanoscaled gold and silver particles

TL;DR: The presented type of biosensing can be a cost-effective and easy to use alternative to conventional biosensing techniques, and also the interband absorption of the particles changes, will be demonstrated.
Journal ArticleDOI

Electrical detection of confined gap plasmons in metal-insulator-metal waveguides

TL;DR: In this paper, an integrated metal-semiconductor-metal photodetector was used to detect gap plasmons in a metal-insulator-metal waveguide and characterize them.
Journal ArticleDOI

Interplay between the magnetic and transport properties in the III-V diluted magnetic semiconductor Ga1-xMnxAs

TL;DR: In this paper, a low-temperature molecular-beam epitaxy growth procedure was used to obtain a III-V diluted magnetic semiconductor with Mn concentrations up to 9% for a critical temperature of 0.03-0.05%.
Journal ArticleDOI

Specific Cell Targeting with Nanobody Conjugated Branched Gold Nanoparticles for Photothermal Therapy

TL;DR: The results suggest that this new type of bioconjugated branched gold nanoparticles are effective antigen-targeted photothermal therapeutic agents for cancer treatment.